Immune Protection Against Chlamydia Trachomatis in Females

Infectious Diseases in Obstetrics and Gynecology

Volumn 4, Issue 3, 1996, Pages 163-170

  Morrison, Richard P ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

C. trachomatis; cervicitis; immunity; pathogen; salpingitis; urethritis

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE TARGETING; IMMUNE RESPONSE; IMMUNITY; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; MORBIDITY; PRIORITY JOURNAL; REINFECTION; T LYMPHOCYTE SUBPOPULATION; UROGENITAL TRACT INFECTION;

EID: 0029797824     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/S106474499600035X     Document Type: Article

References (63)

1. Alani MD, Darougar S, Burns DC, Thin RN, Dunn H: Isolation of Chlamydia trachomatis from the male urethra. Br J Vener Dis 53:88–92, 1977.
2. Barenfanger J, MacDonald AB: The role of immunoglobulin in the neutralization of trachoma infectivity. J Immunol 113:1607–1617, 1974.
3. Batteiger BE, Rank RG: Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun 55:1767–1773, 1987.
4. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 153:4588–4595, 1994.
5. Brunham RC, Kuo C-C, Cles L, Holmes KK: Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 39:1491-1494, 1983.
6. Brunham RC, Martin DH, Kuo C-C, Wang S-P, Stevens CE, Hubbard T, Holmes KK: Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun 34:98-104, 1981.
7. Brunham RC, Peeling R, Maclean I, McDowell J, Persson K, Osser S: Postabortal Chlamydial trachomatis salpingitis: Correlating risk with antigen-specific serological responses and with neutralization. J Infect Dis 155:749-755, 1987.
8. Byrne GL, Grubbs B, Dickey TJ, Schachter J, Williams DM: Interferon in recovery from pneumoniae due to Chlamydia trachomatis in the mouse. J Infect Dis 156:993-996, 1987.
9. Cain TK, Rank RG: Local Thl-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 63:1784-1789, 1995.
10. Cevenini R, Rumpianesi F, Donati M, Moroni A, Sambri V, La Placa M: Class specific immunoglobulin response to individual polypeptides of Chlamydia trachomatis, elementary bodies, and reticulate bodies in patients with chlamydial infection. J Clin Pathol 39:1313-1316, 1986.
11. Cevenini R, Rumpianesi F, Sambri V, La Placa M: Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting. J Clin Pathol 39:325-327, 1986.
12. Cevenini R, Sarov I, Rumpianesi F, Donati M, Melega C, Varotti C, La Placa M: Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol 37:686-691, 1984.
13. Darougar S: The humoral immune response to chlamydial infection in humans. Rev Infect Dis 7:726-730, 1985.
14. Grayston JT, Wang S-P: New knowledge of chlamydiae and the diseases they cause. J Infect Dis 132:87-104, 1975.
15. Grayston JT, Wang S-P, Yeh L-J, Kuo C-C: Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 7:717-725, 1985.
16. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420, 1991.
17. Hallberg T, Wolner-Hanssen P, Mardh P-A: Pelvic inflammatory disease in patients infected with Chlamydia trachomatis: In vitro cell mediated immune response to chlamydial antigens. Genitourin Med 61:247-251, 1985.
18. Hanna L, Schmidt L, Sharp M, Stites DP, Jawetz E: Human cell-mediated immune responses to chlamydial antigens. Infect Immun 23:412-417, 1979.
19. + T cells in antichlamydial immunity defined by chlamydia-specific T-lymphocyte clones. Infect Immun 62:5195-5197, 1994.
20. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG: Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Thl lymphocyte clone. Regional Immunol 5:317-324, 1994.
21. Jawetz E, Rose L, Hanna L, Thygeson P: Experimental inclusion conjunctivitis in man. Measurements of infectivity and resistance. JAMA 194:620-632, 1965.
22. Katz BP, Batteiger BE, Jones RB: Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis 14:160-164, 1987.
23. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426, 1991.
24. 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 86:8932-8935, 1989.
25. Lammert JK: Cytotoxic cells induced after Chlamydia psittaci infection in mice. Infect Immun 35:1011-1017, 1982.
26. Landers DV, Erlich K, Sung M, Schachter J: Role of L3T4-Bearing T-Cell populations in experimental murine chlamydial salpingitis. Infect Immun 59:3774–3777, 1991.
27. Mardh PA: Chlamydial pelvic inflammatory disease. In: P. Reeve (ed.): Chlamydial Infections. Berlin: Springer-Verlag, pp. 45-55.
28. Morrison RP, Feilzer K, Tumas DB: Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 63:4661-4668, 1995.
29. Murray ES, Charbonnet LT, MacDonald AB: Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis. J Immunol 110:1518-1525, 1973.
30. Murray ES, Radcliffe FT: Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (GPIC) Bedsonia. Am J Ophthalmol 63:1263-1269, 1967.
31. Newhall V WJ, Batteiger VB, Jones RB: Analysis of the human serological response to proteins of Chlamydia trachomatis. Infect Immun 38:1181-1189, 1982.
32. Nichols RL, Murray ES, Nisson PE: Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs. J Infect Dis 138:742-746, 1978.
33. Nichols RL, Oertley RE, Fraser CEO, MacDonald AB, McComb DE: Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjunctivae by eye secretions from humans with trachoma. J Infect Dis 127:429-432, 1973.
34. Patton DL, Rank RG: Animal models for the study of pelvic inflammatory disease. In: Gallin JI, Fauci AS (eds.): Advances in host defense mechanisms, 8th ed. New York: Raven Press, Ltd., pp. 85-111.
35. Pavia CS, Schachter J: Failure to detect cell-mediated cytotoxicity against Chlamaydia trachomatis-infected cells. Infect Immun 39:1271-1274, 1983.
36. Qvigstad E, Hirschberg H: Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol Microbiol Immunol Scand (C) 92:153-159, 1984.
37. Ramsey KH, Newhall, V WJ, Rank RG: Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect Immun 57:2441-2446, 1989.
38. Ramsey KH, Rank RG: The role of T cell subpopulations in the resolution of chlamydial genital tract infection of mice. In: Bowie WR, Caldwell HD, Jones RP, Mardh P-A, Ridgway GL, Schachter J, Stamm WE, Ward ME (eds.), Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge: Cambridge University Press, pp. 241-244.
39. Ramsey KH, and Rank RG: Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 59:925-931, 1991.
40. Ramsey KH, Soderberg LSF, Rank RG: Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 56:1320-1325, 1988.
41. Rank RG, Barron AL: Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun 39:463-465, 1983.
42. Rank RG, Barron AL: Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect Immun 55:2317-2319, 1987.
43. Rank RG, Batteiger BE, Soderberg LSF: Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun. 56:2243-2249, 1988.
44. Rank RG, Soderberg LSF, Barron AL: Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 48:847-849, 1985.
45. Rank RG, Soderberg LSF, Sanders MM, Batteiger BE: Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 57:706-710, 1989.
46. Rank RG, White HJ, Barron AL: Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26:573-579, 1979.
47. Schachter J: Chlamydial infections (First of three parts). N Engl J Med 298:428-435, 1978.
48. Schachter J: Chlamydial infections (Second of three parts). N Engl J Med 298:490-495, 1978.
49. Schachter J: Chlamydial infections (Third of three parts). N Engl J Med 298:540-548, 1978.
50. Schachter J, Cles LD, Ray RM, Hesse FE: Is there immunity to chlamydial infections of the human genital tract? Sex Transm Dis 10:123-125, 1983.
51. Starnbach MN, Bevan MJ, Lampe MF: Protective cytotoxic T-lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 153:5183–5189, 1994.
52. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 63:3302-3308, 1995.
53. Tuffrey M, Falder P, Taylor-Robinson D: Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 63:539-546, 1982.
54. Tuffrey M, Falder P, Taylor-Robinson D: Effect of Chlamydia trachomatis infection of the murine genital tract on adoptive transfer of congenic immune cells or specific antibody. Br J Exp Pathol 66:427-433, 1985.
55. Wagar EA, Schachter J, Bavoil P, Stephens RS: Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis 162:922-927, 1990.
56. Wang S-P, Grayston JT, Alexander ER: Trachoma vaccine studies in monkeys. Am J Ophthalmol. 63:1615-1630, 1967.
57. Watson RR, Mull JD, MacDonald AB, Thompson III SE, Bear SE: Immunity to chlamydial infections of the eye. II. Studies of passively transferred serum antibody in resistance to infection with ginea pig inclusion conjunctivitis. Infect Immun 7:597-599, 1973.
58. Williams DM, Grubbs B, Schachter J: Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice. Infect Immun 55:2387-2390, 1987.
59. Williams DM, Magee DM, Bonewald LF, Smith JG, Bleicker CA, Byrne GI, Schachter J: A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun 58:1572-1576, 1990.
60. Williams DM, Schachter J, Grubbs B, Sumaya CV: The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis 145:200-205, 1982.
61. Williams DM, Schachter J, Weiner MH, Grubbs B: Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun 45:674-678, 1984.
62. Woolridge RL, Grayston JT, Chang IH, Yang CY, Cheng KH: Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am J Ophthalmol 63:1650-1655, 1967.
63. Zhang Y-X, Stewart S, Joseph T, Taylor HR, Caldwell HD: Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 138:575-581, 1987.